Company research
Doximity, Inc.
CIK 1516513Updated Sep 27, 2026
DOCS price & chart
Loading TradingView…
NYSE:DOCS on TradingView ↗About the company
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. With new AI-powered clinical reference and search capabilities, Doximity also helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.
In the news
Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf ↗
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm ↗
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS ↗
Recent filings
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,123,687,000Source | 1,264,309,000Source | 1,079,374,000Source | 1,136,888,000Source |
| Property, Plant and Equipment, NetUSD | 18,080,000Source | 13,656,000Source | 12,318,000Source | 11,279,000Source |
| GoodwillUSD | 84,973,000Source | 67,940,000Source | 67,940,000Source | 67,940,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 219,178,000Source | 209,614,000Source | 96,785,000Source | 158,027,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 144,783,000Source | 128,354,000Source | 101,332,000Source | 107,047,000Source |
| Assets, CurrentUSD | 944,264,000Source | 1,088,620,000Source | 912,941,000Source | 975,453,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 50,880,000Source | 44,602,000Source | 48,709,000Source | 22,289,000Source |
| Operating Lease, Right-of-Use AssetUSD | 7,140,000Source | 8,886,000Source | 12,332,000Source | 13,819,000Source |
| Other Assets, NoncurrentUSD | 1,921,000Source | 2,121,000Source | 1,458,000Source | 1,654,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 172,850,000Source | 181,684,000Source | 177,977,000Source | 170,772,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 183,000Source | 189,000Source | 187,000Source | 194,000Source |
| Additional Paid in CapitalUSD | 1,001,688,000Source | 894,225,000Source | 823,885,000Source | 762,150,000Source |
| Retained Earnings (Accumulated Deficit)USD | -51,062,000Source | 186,888,000Source | 79,989,000Source | 217,855,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 28,000Source | 1,323,000Source | -2,664,000Source | -14,083,000Source |
| Stockholders' Equity Attributable to ParentUSD | 950,837,000Source | 1,082,625,000Source | 901,397,000Source | 966,116,000Source |
| Liabilities and EquityUSD | 1,123,687,000Source | 1,264,309,000Source | 1,079,374,000Source | 1,136,888,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 154,973,000Source | 156,257,000Source | 147,250,000Source | 139,507,000Source |
| Operating Lease, Liability, CurrentUSD | 2,110,000Source | 2,211,000Source | 2,149,000Source | 1,752,000Source |
| Accounts Payable, CurrentUSD | 4,009,000Source | 1,356,000Source | 2,253,000Source | 1,272,000Source |
| Operating Lease, Liability, NoncurrentUSD | 8,075,000Source | 10,185,000Source | 12,397,000Source | 13,885,000Source |
| Other Liabilities, NoncurrentUSD | 9,402,000Source | 9,383,000Source | 7,224,000Source | 1,240,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | 38,405,000Source | 43,703,000Source | 31,245,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | — | 809,247,000Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 14,383,000Source | 10,659,000Source | 10,265,000Source | 10,283,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 121,627,000Source | 72,386,000Source | 51,076,000Source | 47,834,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 16,879,000Source | 27,206,000Source | -3,993,000Source | 26,242,000Source |
| Deferred Income Tax Expense (Benefit)USD | 32,138,000Source | -11,592,000Source | -8,593,000Source | 13,226,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 326,458,000Source | 273,265,000Source | 184,096,000Source | 179,602,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 26,528,000Source | 0Source | 0Source | 53,500,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 147,170,000Source | -29,298,000Source | 31,186,000Source | -59,923,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | 0Source | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 0Source | 0Source | 147,000Source | 1,701,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 40,839,000Source | 27,185,000Source | 6,756,000Source | 3,822,000Source |
| Payments for Repurchase of Common StockUSD | 431,652,000Source | 120,293,000Source | 280,716,000Source | 85,324,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -464,064,000Source | -131,138,000Source | -276,524,000Source | -74,461,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 9,564,000Source | 112,829,000Source | -61,242,000Source | 45,218,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 219,178,000Source | 209,614,000Source | 96,785,000Source | 158,027,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 21,814,000Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 121,627,000Source | 72,386,000Source | 51,076,000Source | 47,834,000Source |
| Amortization of Intangible AssetsUSD | 6,500,000Source | 4,300,000Source | 4,600,000Source | 4,800,000Source |
| Capitalized Computer Software, AmortizationUSD | 7,400,000Source | 5,800,000Source | 5,000,000Source | 4,800,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | — | 809,247,000Source |
| DepreciationUSD | 7,900,000Source | 6,400,000Source | 5,700,000Source | 5,500,000Source |
| Gain (Loss) on InvestmentsUSD | 188,000Source | 169,000Source | -402,000Source | -1,093,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | 0Source |
| General and Administrative ExpenseUSD | 65,267,000Source | 45,670,000Source | 37,827,000Source | 36,745,000Source |
| GoodwillUSD | 84,973,000Source | 67,940,000Source | 67,940,000Source | 67,940,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | — | — | — |
| Income Tax Expense (Benefit)USD | 53,954,000Source | 40,389,000Source | 37,620,000Source | 20,338,000Source |
| Net Income (Loss) Attributable to ParentUSD | 196,051,000Source | 223,185,000Source | 147,582,000Source | 112,818,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 147,582,000Source | 112,818,000Source |
| Nonoperating Income (Expense)USD | 35,085,000Source | — | — | — |
| Operating ExpensesUSD | 359,617,000Source | 286,725,000Source | 260,875,000Source | 240,454,000Source |
| Other Nonoperating Income (Expense)USD | -806,000Source | -247,000Source | 62,000Source | 8,048,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 561,434,000Source | 635,401,000Source | 435,179,000Source | 83,139,000Source |
| Restructuring Costs and Asset Impairment ChargesUSD | 0Source | — | — | — |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 644,863,000Source | 570,399,000Source | 475,422,000Source | 419,052,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | 214,920,000Source | 227,800,000Source | 163,878,000Source | 125,108,000Source |
| Other Nonoperating Income (Expense)USD | -806,000Source | -247,000Source | 62,000Source | 8,048,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 250,005,000Source | 263,574,000Source | 185,202,000Source | 133,156,000Source |
| Income Tax Expense (Benefit)USD | 53,954,000Source | 40,389,000Source | 37,620,000Source | 20,338,000Source |
| Net Income (Loss) Attributable to ParentUSD | 196,051,000Source | 223,185,000Source | 147,582,000Source | 112,818,000Source |
| Earnings Per Share, BasicUSD per share | 1.05Source | 1.19Source | 0.78Source | 0.58Source |
| Earnings Per Share, DilutedUSD per share | 0.98Source | 1.11Source | 0.72Source | 0.53Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 187,014,000Source | 186,841,000Source | 190,172,000Source | 193,176,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 199,048,000Source | 201,208,000Source | 205,734,000Source | 213,425,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 6,500,000Source | 4,300,000Source | 4,600,000Source | 4,800,000Source |
| Capitalized Computer Software, AmortizationUSD | 7,400,000Source | 5,800,000Source | 5,000,000Source | 4,800,000Source |
| Current Income Tax Expense (Benefit)USD | 21,816,000Source | — | — | — |
| Gain (Loss) on InvestmentsUSD | 188,000Source | 169,000Source | -402,000Source | -1,093,000Source |
| General and Administrative ExpenseUSD | 65,267,000Source | 45,670,000Source | 37,827,000Source | 36,745,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | 574,537,000Source | 514,525,000Source | 424,753,000Source | 365,562,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | 35,703,000Source | 35,852,000Source | 21,664,000Source | 9,287,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 147,582,000Source | 112,818,000Source |
| Nonoperating Income (Expense)USD | 35,085,000Source | — | — | — |
| Operating ExpensesUSD | 359,617,000Source | 286,725,000Source | 260,875,000Source | 240,454,000Source |
| Research and Development ExpenseUSD | 130,702,000Source | 93,038,000Source | 81,983,000Source | 80,186,000Source |
| Selling and Marketing ExpenseUSD | 163,648,000Source | 145,713,000Source | 133,129,000Source | 123,523,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | — | — | 0Source | 0Source |
Filing attachments
doximity-2026630xex991.htm · 8-K · 2026-08-06
EX-99.1 2 doximity-2026630xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2027 First Quarter Financial Results Total revenues of $156.6 million, up 7% year-over-year Net income of $24.3 million, margin of 16% Adjusted EBITDA of $74.8 million, margin of 48% SAN FRANCISCO, Calif., August 6, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026. “We'…
Read attachment ↗doximity-2026331xex991.htm · 8-K · 2026-05-13
EX-99.1 2 doximity-2026331xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results Fiscal year 2026 total revenues of $644.9 million, up 13% year-over-year Fiscal year 2026 operating cash flows of $326.5 million, up 19% year-over-year Fiscal year 2026 free cash flow of $317.5 million, up 19% year-over-year SAN FRANCISCO, Calif., May 13, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professiona…
Read attachment ↗doximity-20251231xex991.htm · 8-K · 2026-02-05
EX-99.1 2 doximity-20251231xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2026 Third Quarter Financial Results Total revenues of $185.1 million, up 10% year-over-year Net income of $61.6 million, margin of 33% Adjusted EBITDA of $111.4 million, margin of 60% SAN FRANCISCO, Calif., February 5, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 20…
Read attachment ↗doximity-2025930xex991.htm · 8-K · 2025-11-06
EX-99.1 2 doximity-2025930xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2026 Second Quarter Financial Results Total revenues of $168.5 million, up 23% year-over-year Operating cash flow of $93.9 million, up 37% year-over-year Free cash flow of $91.6 million, up 37% year-over-year SAN FRANCISCO, Calif., November 6, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quart…
Read attachment ↗doximity-2025630xex991.htm · 8-K · 2025-08-07
EX-99.1 2 doximity-2025630xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2026 First Quarter Financial Results Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year SAN FRANCISCO, Calif., August 7, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter e…
Read attachment ↗doximity-2025613xex991.htm · 8-K · 2025-06-13
EX-99.1 2 doximity-2025613xex991.htm EX-99.1 Document Thank you, Nate! After 15 wonderful years, our co-founder, partner, and pyramid topper (!), Dr. Nate Gross is moving on. He’ll remain an advisor here at Doximity, but not in a day-to-day role. We will miss him. I first met Nate when he was co-founding Rock Health back in 2009. I recall being so impressed that he’d re-engineered his hospital’s pager software to run on his iPhone. He was then, and remains now, a human encyclopedia of dig…
Read attachment ↗